← Sites
703 (USA)
USA
PI: Dr. Okafor
activated
KRI 0.2
Patients
19
Active (enrolled/consented)
0
Withdrawn
4
Serious AEs
0
Open QA findings
2
Aged data queries
0
Studies & contracts total budget 225500.00 USD
Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
study completed
contract executed
225500 USD
Patients first 19
| Ref | Status | Consented | Study |
|---|---|---|---|
| 703-1042 | completed | 2013-03-02 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 703-1076 | completed | 2013-10-25 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 703-1086 | completed | 2012-09-02 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 703-1096 | withdrawn | 2013-01-25 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 703-1100 | completed | 2013-03-13 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 703-1119 | completed | 2013-02-20 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 703-1175 | completed | 2013-12-20 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 703-1182 | completed | 2013-10-17 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 703-1197 | withdrawn | 2013-06-16 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 703-1210 | completed | 2013-03-16 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 703-1258 | completed | 2012-07-20 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 703-1279 | withdrawn | 2013-05-13 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 703-1295 | withdrawn | 2013-11-21 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 703-1299 | completed | 2012-09-12 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 703-1335 | completed | 2014-03-17 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 703-1379 | completed | 2013-09-22 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 703-1396 | screened | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. | |
| 703-1403 | completed | 2012-12-12 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 703-1439 | completed | 2014-03-12 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
Luna participants (0)
No participants at this site use Luna yet.
Safety 61 AEs · 0 serious
No serious adverse events at this site.
QA findings 2 open
open
major
Protocol deviation
PROTOCOL VIOLATION: PROTOCOL ENTRY CRITERIA NOT MET (subject 703-1175, 2013-12-31)
open
major
Protocol deviation
PROTOCOL VIOLATION: PROTOCOL VIOLATION (subject 703-1335, 2014-05-24)
Monitoring visits (0)
No visits recorded.
Payments (0)
No payments on file.